Cascade Financial Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Cascade Financial Partners's MRK Position: Q3 2026 in Review
Cascade Financial Partners increased its Merck (MRK) stake by 1.6% in Q3 2026, buying an estimated $32.7K and bringing the position to 14,983 shares worth $2.18M. The position accounts for 0.18% of the portfolio, ranked #83.
Cascade Financial Partners first reported a position in MRK in Q1 2024 and has held it in 11 quarters since. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Cascade Financial Partners held 14,983 shares of Merck worth $2.18M as of Q3 2026.
- Cascade Financial Partners bought 237 Merck shares in Q3 2026, an estimated $32.7K.
- Merck made up 0.18% of Cascade Financial Partners's portfolio in Q3 2026, its #83 holding.
- Cascade Financial Partners first reported a position in Merck in Q1 2024 and has held it in 11 quarters since.
- 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Cascade Financial Partners's 13F filing for Q3 2026, filed 16 Nov 2026.